How Successful is Switching from Bevacizumab or Ranibizumab to Aflibercept in Age-Related Macular Degeneration? A Systematic Overview.
Adv Ther
; 36(7): 1532-1548, 2019 07.
Article
in En
| MEDLINE
| ID: mdl-31102206
Full text:
1
Database:
MEDLINE
Main subject:
Recombinant Fusion Proteins
/
Drug Substitution
/
Bevacizumab
/
Ranibizumab
/
Macular Degeneration
Type of study:
Guideline
/
Overview
/
Prognostic_studies
/
Systematic_reviews
Limits:
Aged
/
Humans
Language:
En
Journal:
Adv Ther
Journal subject:
TERAPEUTICA
Year:
2019
Type:
Article
Affiliation country:
United kingdom